STAT December 23, 2025
In China’s biotech sector, hypercompetition and speed are rewriting the rules of drug discovery
Something remarkable is happening in Chinese biotech, and it’s happening fast. The country’s drug developers are learning to run — really run — through clinical trials and regulatory approvals. In an industry famous for glacial timelines and billion-dollar budgets, China’s pace feels almost alien.
Chinese companies are developing drugs faster and cheaper than anyone else, including the U.S. And while...
Today's Sponsors
Today's Sponsor